Janus Henderson Group
PALI icon

Janus Henderson Group’s Palisade Bio PALI Stock Holding History

Janus Henderson Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8M Buy
10,689,452
+149,118
+1% +$271K 0.01% 618
2025
Q4 		$24.8M Buy
+10,540,334
New +$20.3M 0.01% 561

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Janus Henderson Group's PALI Position: Q1 2026 in Review

Janus Henderson Group increased its Palisade Bio (PALI) stake by 1.4% in Q1 2026, buying an estimated $271K and bringing the position to 10,689,452 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #618.

Janus Henderson Group first reported a position in PALI in Q4 2025 and has held it in 2 quarters since. The position peaked at $24.8M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Janus Henderson Group held 10,689,452 shares of Palisade Bio worth $18.8M as of Q1 2026.
  • Janus Henderson Group bought 149,118 Palisade Bio shares in Q1 2026, an estimated $271K.
  • Palisade Bio made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #618 holding.
  • Janus Henderson Group first reported a position in Palisade Bio in Q4 2025 and has held it in 2 quarters since.
  • Janus Henderson Group's Palisade Bio position peaked at $24.8M in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.